1. Home
  2. KRRO vs MMD Comparison

KRRO vs MMD Comparison

Compare KRRO & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • MMD
  • Stock Information
  • Founded
  • KRRO 2014
  • MMD 2012
  • Country
  • KRRO United States
  • MMD United States
  • Employees
  • KRRO N/A
  • MMD N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • MMD Investment Managers
  • Sector
  • KRRO Health Care
  • MMD Finance
  • Exchange
  • KRRO Nasdaq
  • MMD Nasdaq
  • Market Cap
  • KRRO 490.1M
  • MMD 439.8M
  • IPO Year
  • KRRO 2019
  • MMD N/A
  • Fundamental
  • Price
  • KRRO $43.67
  • MMD $14.85
  • Analyst Decision
  • KRRO Strong Buy
  • MMD
  • Analyst Count
  • KRRO 7
  • MMD 0
  • Target Price
  • KRRO $133.83
  • MMD N/A
  • AVG Volume (30 Days)
  • KRRO 132.1K
  • MMD 74.7K
  • Earning Date
  • KRRO 11-12-2024
  • MMD 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • MMD 4.88%
  • EPS Growth
  • KRRO N/A
  • MMD N/A
  • EPS
  • KRRO N/A
  • MMD N/A
  • Revenue
  • KRRO N/A
  • MMD N/A
  • Revenue This Year
  • KRRO N/A
  • MMD N/A
  • Revenue Next Year
  • KRRO N/A
  • MMD N/A
  • P/E Ratio
  • KRRO N/A
  • MMD N/A
  • Revenue Growth
  • KRRO N/A
  • MMD N/A
  • 52 Week Low
  • KRRO $30.01
  • MMD $14.30
  • 52 Week High
  • KRRO $98.00
  • MMD $17.67
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 43.00
  • MMD 23.02
  • Support Level
  • KRRO $41.03
  • MMD $15.60
  • Resistance Level
  • KRRO $52.00
  • MMD $15.46
  • Average True Range (ATR)
  • KRRO 6.03
  • MMD 0.27
  • MACD
  • KRRO 0.03
  • MMD -0.08
  • Stochastic Oscillator
  • KRRO 42.36
  • MMD 1.37

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund

MainStay MacKay DefinedTerm Municipal Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company may also invest in TOB (Tender Option Bonds) Floaters and TOB Residuals issued by the TOB Issuer. It evaluates its performance against Barclays Municipal Bond Index.

Share on Social Networks: